Mercer Global Advisors
AEMD icon

Mercer Global Advisors’s Aethlon Medical AEMD Stock Holding History

Mercer Global Advisors’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17
Closed -$5K – 1951
2023
Q2 		$5K Hold
17
– – ﹤0.01% 1909
2023
Q1 		$5K Hold
17
– – ﹤0.01% 1920
2022
Q4 		$4K Hold
17
– – ﹤0.01% 1921
2022
Q3 		$8K Buy
+17
New +$14.7K ﹤0.01% 1810

Other funds holding AEMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFGAS
Allegiance Financial Group Advisory Services Vienna, Virginia $503M AUM 22.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIA
Panoramic Investment Advisors Denver, Colorado $185M AUM 18.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mercer Global Advisors's AEMD Position: Q3 2023 in Review

Mercer Global Advisors sold out of Aethlon Medical (AEMD) in Q3 2023, closing a stake of 17 shares — an estimated $5K sold.

Mercer Global Advisors first reported a position in AEMD in Q3 2022 and held it in 4 quarters. The position peaked at $8K in Q3 2022. 21 funds tracked by Wall St. Rank hold AEMD as of Q3 2023.

  • Mercer Global Advisors reported no remaining Aethlon Medical position as of Q3 2023 after selling out during the quarter.
  • Mercer Global Advisors sold 17 Aethlon Medical shares in Q3 2023, an estimated $5K.
  • Mercer Global Advisors first reported a position in Aethlon Medical in Q3 2022 and held it in 4 quarters.
  • Mercer Global Advisors's Aethlon Medical position peaked at $8K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Aethlon Medical as of Q3 2023.

Based on Mercer Global Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.